Shift to Offensive Strategies in 2025: New Molluscum Contagiosum Treatment | Becoming A Pharmacy Badass

**Dr. Lisa Faast explains why 2025 is the year to move from defense to offense in your pharmacy business. She shares actionable strategies to help you recapture growth and profitability in the year ahead.** **Show Notes:** 1. **FDA-approved treatment for molluscum contagiosum in pediatric patients** [0:0] <br> Order Details: 🔹Order from FFF Enterprises (create account HERE: https://sfyx-zgpvh.maillist-manage.net/click/1aebbcaa6da1a714/1aebbcaa6da16ba8) 🔹Order NDC: 71349-0070-06 (outer box NDC) 🔹Bill NDC: 71349-0070-01 (inner single applicator) 🔹Approved for Molluscum Contagiosum 📥 Click the links below to download helpful resources: 👉Verrica Ycanth – DiversifyRx Presentation: https://membership.diversifyrx.com/wp-content/uploads/2024/12/Verrica-Ycanth-DiversifyRx-Final-Slides-December-10.pptx 👉Ycanth – Cantharidin Marketing Materials:https://membership.diversifyrx.com/resources/ycanth-cantharidin-marketing-materials/ Websites Mentioned: https://www.drlisafaast.com/ ----- #### **Becoming a Badass Pharmacy Owner Podcast is a Proud to be Apart of the Pharmacy Podcast Network**

There are no comments yet.

Please log in to write the first comment.